179 related articles for article (PubMed ID: 26792819)
1. Myosin-IIA regulates leukemia engraftment and brain infiltration in a mouse model of acute lymphoblastic leukemia.
Wigton EJ; Thompson SB; Long RA; Jacobelli J
J Leukoc Biol; 2016 Jul; 100(1):143-53. PubMed ID: 26792819
[TBL] [Abstract][Full Text] [Related]
2. The Formin mDia1 Regulates Acute Lymphoblastic Leukemia Engraftment, Migration, and Progression
Thompson SB; Wigton EJ; Krovi SH; Chung JW; Long RA; Jacobelli J
Front Oncol; 2018; 8():389. PubMed ID: 30294591
[TBL] [Abstract][Full Text] [Related]
3. A farnesyltransferase inhibitor increases survival of mice with very advanced stage acute lymphoblastic leukemia/lymphoma caused by P190 Bcr/Abl.
Mishra S; Zhang B; Groffen J; Heisterkamp N
Leukemia; 2004 Jan; 18(1):23-8. PubMed ID: 14603339
[TBL] [Abstract][Full Text] [Related]
4. Nonmuscle myosin IIA is associated with poor prognosis of esophageal squamous cancer.
Xia ZK; Yuan YC; Yin N; Yin BL; Tan ZP; Hu YR
Dis Esophagus; 2012 Jul; 25(5):427-36. PubMed ID: 21951916
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo priming of CD4 T cells converts immunological tolerance into effective antitumor immunity in a murine model of acute lymphoblastic leukemia.
Hegazy AN; Klein C
Leukemia; 2008 Nov; 22(11):2070-9. PubMed ID: 18633431
[TBL] [Abstract][Full Text] [Related]
6. The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.
Williams RT; Sherr CJ
Adv Exp Med Biol; 2007; 604():107-14. PubMed ID: 17695724
[TBL] [Abstract][Full Text] [Related]
7. Role of Vitamins A and D in BCR-ABL Arf
Annu K; Cline C; Yasuda K; Ganguly S; Pesch A; Cooper B; Janke L; Payton M; Mukherjee K; Surman SL; Hurwitz JL; Schuetz EG
Sci Rep; 2020 Feb; 10(1):2359. PubMed ID: 32047189
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia.
William BM; Goodrich A; Peng C; Li S
Hematology; 2008 Dec; 13(6):333-43. PubMed ID: 19055861
[TBL] [Abstract][Full Text] [Related]
9. The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemia.
Ma H; Mallampati S; Lu Y; Sun B; Wang E; Leng X; Gong Y; Shen H; Yin CC; Jones D; Amin HM; You MJ; Zweidler-McKay P; Ma Y; Kantarjian HM; Arlinghaus RB; Glassman A; Sun X
Haematologica; 2014 Oct; 99(10):1591-8. PubMed ID: 24997151
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rg1 Protects against Oxidative Stress-induced Neuronal Apoptosis through Myosin IIA-actin Related Cytoskeletal Reorganization.
Wang Y; Liu Q; Xu Y; Zhang Y; Lv Y; Tan Y; Jiang N; Cao G; Ma X; Wang J; Cao Z; Yu B; Kou J
Int J Biol Sci; 2016; 12(11):1341-1356. PubMed ID: 27877086
[TBL] [Abstract][Full Text] [Related]
11. Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells.
Manlove LS; Berquam-Vrieze KE; Pauken KE; Williams RT; Jenkins MK; Farrar MA
J Immunol; 2015 Oct; 195(8):4028-37. PubMed ID: 26378075
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a new Philadelphia chromosome-positive acute lymphoblastic leukemia cell line (SK-9) with T315I mutation.
Okabe S; Tauchi T; Ohyashiki K
Exp Hematol; 2010 Sep; 38(9):765-72. PubMed ID: 20471447
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles of nonmuscle myosin II isoforms in the regulation of MDA-MB-231 breast cancer cell spreading and migration.
Betapudi V; Licate LS; Egelhoff TT
Cancer Res; 2006 May; 66(9):4725-33. PubMed ID: 16651425
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
[TBL] [Abstract][Full Text] [Related]
15. The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA.
Huang Y; Arora P; McCulloch CA; Vogel WF
J Cell Sci; 2009 May; 122(Pt 10):1637-46. PubMed ID: 19401332
[TBL] [Abstract][Full Text] [Related]
16. Crk-associated substrate lymphocyte type regulates myeloid cell motility and suppresses the progression of leukemia induced by p210Bcr/Abl.
Seo S; Nakamoto T; Takeshita M; Lu J; Sato T; Suzuki T; Kamikubo Y; Ichikawa M; Noda M; Ogawa S; Honda H; Oda H; Kurokawa M
Cancer Sci; 2011 Dec; 102(12):2109-17. PubMed ID: 21848808
[TBL] [Abstract][Full Text] [Related]
17. Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia.
Jost TR; Borga C; Radaelli E; Romagnani A; Perruzza L; Omodho L; Cazzaniga G; Biondi A; Indraccolo S; Thelen M; Te Kronnie G; Grassi F
J Leukoc Biol; 2016 Jun; 99(6):1077-87. PubMed ID: 26931577
[TBL] [Abstract][Full Text] [Related]
18. The induction of CD10 on a pre-B leukemia cell line occurs with progression of the disease in scid mice.
Ishii E; Greaves A; Grunberger T; Freedman MH; Letarte M
Leukemia; 1993 Oct; 7(10):1592-601. PubMed ID: 7692193
[TBL] [Abstract][Full Text] [Related]
19. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ
Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the CDR3 structure of the Vβ21 T cell clone in patients with P210(BCR-ABL)-positive chronic myeloid leukemia and B-cell acute lymphoblastic leukemia.
Zha X; Chen S; Yang L; Li B; Chen Y; Yan X; Li Y
Hum Immunol; 2011 Oct; 72(10):798-804. PubMed ID: 21820025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
